Silicon BioDevices has developed the next generation point-of-care testing (POCT) technology: a small disposable device with integrated display that measures multiple analytes directly from a finger stick of blood and instantly transfers the results to a mobile device or wireless server accessed electronic medical record (EMR) system. This breakthrough innovation will help integrate in vitro diagnostic test information into patient care workflow and allow many more blood tests to be performed in non-medical settings. This disruptive approach raises the bar on body fluid testing at the point of specimen collection by delivering performance equal to the clinical laboratory.

On April 18, 2013 the company presented its innovative assay platform at the 45th annual Oak Ridge Conference.